Ikarian-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
141
Total Value
710178588
Accession Number
0001420506-25-001276
Form Type
13F-HR
Manager Name
Ikarian-Capital
Data Enrichment
96% identified
135 identified6 unidentified

Holdings

141 positions • $710.2M total value
Manager:
Search and click to pin securities to the top
Page 8 of 8
RELMADA THERAPEUTICS, INC.
Shares:40.3K
Value:$10.9K
% of Portfolio:0.0% ($10.9K/$710.2M)